Apexigen Reports Third Quarter 2022 Financial Results and :

-Ongoing Phase 2 trial in collaboration with Columbia University demonstrated that sotigalimab (sotiga) in combination with doxorubicin achieved a median...

Related Keywords

, Xiaodong Yang , Brookline Capital Acquisition Corp , Society For Immunotherapy Of Cancer , Apexigen Inc , Securities Exchange , European Society For Medical Oncologists , Nasdaq , Columbia University , Ongoing Phase , Chief Executive Officer , Program Highlights , Anticipated Upcoming Milestones , Medical Oncologists , Annual Meeting , Brookline Capital Acquisition , Lincoln Park , Securities Act , Securities Exchange Act , Nasdaq Apgn , Apexigen ,